Inflammation and Oxidative Stress in Snakebite Envenomation: A Brief Descriptive Review and Clinical Implications

Toxins (Basel). 2022 Nov 18;14(11):802. doi: 10.3390/toxins14110802.

Abstract

Snakebite envenoming is a pathological condition which may occur in response to the injection of venom. Snake venoms contain a complex mixture of biologically active molecules which are responsible for a broad spectrum of clinical manifestations, ranging from local tissue injuries to fatal complications. Snake venom administration commonly provokes local tissue injury often associated with systemic effects, including neurotoxic and cardiotoxic manifestations, bleeding, acute kidney injury, and rhabdomyolysis. An important spectrum of pathogenesis of snake envenomation is the generation of reactive oxygen species (ROS), which can directly provoke tissue damage and also potentiate the deleterious consequences of inflammation at the bite site. Snake venom components known to induce oxidative stress include phospholipases A2, metalloproteinases, three-finger toxins, and L-amino acid oxidase. Clear evidence is mounting suggesting that inflammation and oxidative stress participate in the destructive effects of envenoming, including acute renal failure, tissue necrosis, and unusual susceptibility to bleed (hemorrhage), mostly due to hypocoagulability, neuro/cardio toxicity, and myonecrosis. Impaired regulation of oxidative stress may also set the stage for secondary/long-term complications of snakebite envenomation such as musculoskeletal disabilities. Some aspects of natural antioxidant therapeutic options are discussed in this review.

Keywords: L-amino acid oxidase; antioxidant; elapids; metalloproteinases; oxidative stress; phospholipases A2; snakebite; three-finger cardiotoxins; venom; viperids.

Publication types

  • Review
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Acute Kidney Injury* / etiology
  • Humans
  • Inflammation
  • Oxidative Stress
  • Reactive Oxygen Species
  • Snake Bites* / complications
  • Snake Bites* / drug therapy

Substances

  • Reactive Oxygen Species

Grants and funding

This work was supported by the Agence Nationale de la Recherche ANR-18-CE17-0026-01 to RN and ANR-18-CE17-0026-03 to DR (https://anr.fr/Project-ANR-18-CE17-0026 , accessed on 10 November 2022). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.